Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
capecitabine (xeloda) (1 trial)
fluorouracil (efudex) (1 trial)
Carcinoma (Phase 3)
Nasopharyngeal Carcinoma (Phase 3)
Trials (1 total)
Trial APIs (2 total)